Based upon clinical studies showing increasing concentration of MMP-1, -7, -8, and -9 in idiopathic pulmonary fibrosis (IPF) in blood and lung samples, targeting MMPs and their inhibitors may be new therapeutic approaches for IPF (reviewed in44). Here, MMP1 is linked to idiopathic pulmonary fibrosis.